Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B.

Viruses - 11 Mar 2022

Gozlan Yael, Aaron Daniella, Davidov Yana, Likhter Maria, Ben Yakov Gil, Cohen-Ezra Oranit, Picard Orit, Erster Oran, Mendelson Ella, Ben-Ari Ziv, Abu Baker Fadi, Mor Orna

Abstract excerpt

A comprehensive characterization of chronic HBV (CHB) patients is required to guide therapeutic decisions. The cumulative impact of classical and novel biomarkers on the clinical categorization of these patients has not been rigorously assessed. We determined plasma HBV-RNA and HBsAg levels, HBV in peripheral lymphocytes (PBMCs) and HBV mutation profiles in CHB patients. Patient demographics (n = 139) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to DNA, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Lymphocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 35336990
DOI: 10.3390/v14030584
PMCID: PMC8949614

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B.PMID 35336990Read ↗

Molecular testing in the diagnosis and management of chronic hepatitis B.Semantic proximity Read ↗

Molecular methods in the diagnosis and management of chronic hepatitis B.Semantic proximity Read ↗

Diagnosis of chronic hepatitis B and the implications of viral variants and mutations.Semantic proximity Read ↗

Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection.Semantic proximity Read ↗

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.Semantic proximity Read ↗

New perspectives of biomarkers for the management of chronic hepatitis B.Semantic proximity Read ↗

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.Semantic proximity Read ↗

Re-appraisal of old and new diagnostic tools in the current management of chronic hepatitis B.Semantic proximity Read ↗

Virological and serological tools to optimize the management of patients with chronic hepatitis B.Semantic proximity Read ↗

Serological, molecular characteristics and cytokines profile of HBsAg negative/HBV DNA positive patients in clinicSemantic proximity Read ↗

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.Semantic proximity Read ↗

HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.